KRISTEN MARITATO: Open Payments
NPI 1225466899 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 151 payments from 21 companies in 2025. Trend: 2023 $1,389 · 2024 $1,762 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $450 |
| Novo Nordisk Inc | 22 | $328 |
| Phathom Pharmaceuticals, Inc. | 9 | $244 |
| AstraZeneca Pharmaceuticals LP | 5 | $218 |
| PFIZER INC. | 18 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $189 |
| Otsuka America Pharmaceutical, Inc. | 10 | $163 |
| Lilly USA, LLC | 10 | $147 |
| GlaxoSmithKline, LLC. | 7 | $125 |
| Axsome Therapeutics, Inc. | 6 | $95 |
Products named: UBRELVY, VOQUEZNA, REXULTI, XIFAXAN, BREZTRI, QULIPTA, JARDIANCE, Wegovy.
Industry payments across PA — which companies pay providers there.
